Cocaine analgesia: an in vivo structure-activity study

Area of Science:

• Pharmacology
• Neuroscience
• Medicinal Chemistry

Background:

• Cocaine possesses analgesic properties, but its therapeutic use is limited by abuse potential and side effects.
• Understanding the structure-activity relationships of cocaine analogues is crucial for developing safer analgesics.

Purpose of the Study:

• To determine the optimal analgesic doses of intracerebroventricularly administered cocaine, its metabolites, and related compounds.
• To elucidate the key structural determinants of analgesic activity in cocaine derivatives.

Main Methods:

• Hot plate testing in rats to assess antinociceptive effects.
• Intracerebroventricular (ICV) administration of various compounds, including cocaine, cocaethylene, benzoylecgonine, norcocaine, ecgonine, and ecgonine methyl ester.
• Dose-response analysis to identify optimal analgesic concentrations.

Main Results:

• Optimal analgesic doses (in microM) were identified for cocaine (0.37), cocaethylene (0.09), benzoylecgonine (0.35), norcocaine (0.43), and ecgonine (2.1).
• Ecgonine methyl ester showed no analgesic effect at doses up to 3.7 microM.
• Key structural features influencing analgesia include a hydrophobic C-3 group, a hydrophobic C-2 ester group, and stereochemistry.

Conclusions:

• A hydrophobic group at the C-3 position is critical for analgesic activity.
• Ester groups at the C-2 position can enhance pain-relieving effects.
• The N-methyl group has minimal impact, while isomeric changes can modulate analgesia, providing insights for novel analgesic drug design.